Tissue‐resident CXCR4 + macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression
International Journal of Cancer · 2023-06 · 152 (11) · 2396-2409
DOI: 10.1002/ijc.34468 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 21.02.2023. Verfasst von Zhenyu Liao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Shanghai Cancer Centre, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Macrophage is an essential part of the tumor immune microenvironment of pancreatic ductal adenocarcinoma. In our study, we explored the CXCR4 + macrophages subset on its prognosis value, immune profile and distinct function in pancreatic cancer progression. Specimens from 102 postoperative pancreatic patients were analyzed by flow cytometry or immune‐fluorescence, and the prognostic value of CXCR4 + macrophages infiltration was further determined by Cox regression. In silico analysis on TCGA, ICGC database and single‐cell sequencing of pancreatic ductal adenocarcinoma further validated our findings. We found that high CXCR4 + macrophages infiltration was associated with poor overall survival ( P < .01) and disease‐free survival ( P < .05) as an independent factor. CXCR4 + macrophages exhibited an M2 protumor phenotype with high expression of CD206. The function of CXCR4 + macrophages was further analyzed in the murine orthotopic PDAC model with its tumor promotion effect and inhibition of CD8 + T cells. Mechanistic and RNA‐seq analysis showed that CXCR4 + macrophages participated in extracellular matrix remodeling procedures and especially secreted SPARC through CXCR4/PI3K/Akt pathway promoting tumor proliferation and migration. Our study reveals that CXCR4 + macrophages infiltration is an indicator of poor prognosis of PDAC and targeting these cells was potentially crucial in immunotherapy of PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pancreatic Surgery, Shanghai Cancer Centre, Fudan University, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Shanghai Pancreatic Cancer Institute, Shanghai, China.
- Pancreatic Cancer Institute, Fudan University, Shanghai, China.
ORCID-Profile: Weiding Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Liao, Z., Ye, L., Li, T., Jin, X., Lin, X., Fei, Q., Zhang, H., Shi, S., Yu, X., Jin, K., & Wu, W. (2023). Tissue‐resident CXCR4 + macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. International Journal of Cancer, 152(11), 2396-2409. https://doi.org/10.1002/ijc.34468
Vancouver
Liao Z, Ye L, Li T, Jin X, Lin X, Fei Q, et al. Tissue‐resident CXCR4 + macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. International Journal of Cancer. 2023;152(11):2396-2409. doi:10.1002/ijc.34468
BibTeX
@article{Liao2023,
author = {Liao, Zhenyu and Ye, Longyun and Li, Tianjiao and Jin, Xing and Lin, Xuan and Fei, Qinglin and Zhang, Huiru and Shi, Saimeng and Yu, Xianjun and Jin, Kaizhou and Wu, Weiding},
title = {Tissue‐resident CXCR4 + macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression},
journal = {International Journal of Cancer},
year = {2023},
volume = {152},
number = {11},
pages = {2396--2409},
doi = {10.1002/ijc.34468}
}
EUVIMED